Knoll Capital Management, LLC
Follow13F filer, CIK 1325083, MIAMI, FL
Knoll Capital Management, LLC reported $214,313,482 across 37 holdings for the quarter ended 2026-06-30, in a 13F-HR/A filed 2026-09-10. Its ten largest share positions make up 62.01% of the portfolio.
Accepted , ingested 13F-HR/A 0001104659-26-106457
- Period
- 2026-06-30
- Reported value
- $214M
- Holdings
- 37
- Top 10 weight
- 62.01%
- New
- 1
- Sold out
- 1
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| OCULadded | +550,000 | $5.4M |
| ABVXnew | +35,000 | $4.66M |
| ELTXadded | +581,042 | $2.27M |
| NUVBadded | +100,000 | $568K |
| BIOHAVEN PHARMACEUTICAL HOL…added | +23,918 | $356K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CRDLexited | -100,000 | -$135K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2026
Share positions as resolved from 13F-HR/A 0001104659-26-106457, largest first. % of portfolio is the value over $214,313,482, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOL…BIOHAVEN PHARMACEUTICAL HOLDIN | 2,352,520 | $35M | 16.33% | +23,918 | |||
| MGTXMEIRAGTX HLDGS PLC | 1,250,000 | $16.9M | 7.88% | 0 | Timeline | ||
| PHYSSPROTT ASSET MANAGEMENT LP | 387,055 | $11.7M | 5.45% | 0 | Timeline | ||
| ALDXALDEYRA THERAPEUTICS INC | 5,475,516 | $11.7M | 5.44% | 0 | Timeline | ||
| OCULOCULAR THERAPEUTIX INC | 1,150,400 | $11.3M | 5.27% | +550,000 | Timeline | ||
| RGLDROYAL GOLD INC | 52,750 | $10.5M | 4.91% | 0 | Timeline | ||
| ENTXENTERA BIO LTD | 5,881,879 | $10.4M | 4.86% | 0 | Timeline | ||
| NUVBNUVATION BIO INC | 1,598,591 | $9.08M | 4.24% | +100,000 | Timeline | ||
| AEMAGNICO EAGLE MINES LTD | 52,750 | $8.18M | 3.82% | 0 | Timeline | ||
| SASEABRIDGE GOLD INC | 317,003 | $8.16M | 3.81% | 0 | Timeline | ||
| KGCKINROSS GOLD CORP | 320,000 | $7.56M | 3.53% | 0 | Timeline | ||
| OROR ROYALTIES INC. | 225,000 | $7.12M | 3.32% | 0 | Timeline | ||
| SSRMSSR MINING IN | 245,000 | $6.93M | 3.23% | 0 | Timeline | ||
| FNVFRANCO NEV CORP | 32,000 | $6.67M | 3.11% | 0 | Timeline | ||
| CGAUCENTERRA GOLD INC | 359,000 | $5.69M | 2.66% | 0 | Timeline | ||
| BAHBOOZ ALLEN HAMILTON HLDG COR | 13,000 | $5.69M | 2.66% | 0 | Timeline | ||
| ELTXELICIO THERAPEUTICS INC | 1,211,957 | $4.74M | 2.21% | +581,042 | Timeline | ||
| ABVXABIVAX SA | 35,000 | $4.66M | 2.18% | new | Timeline | ||
| PAASPAN AMERN SILVER CORP | 100,035 | $4.48M | 2.09% | 0 | Timeline | ||
| PSLVSPROTT ASSET MANAGEMENT LP | 222,160 | $4.19M | 1.96% | 0 | Timeline | ||
| TFPMTRIPLE FLAG PRECIOUS METAL | 115,000 | $3.45M | 1.61% | 0 | Timeline | ||
| ABEOABEONA THERAPEUTICS INC | 485,515 | $3M | 1.4% | 0 | Timeline | ||
| GROYGOLD ROYALTY CORP | 1,000,000 | $2.76M | 1.29% | 0 | Timeline | ||
| NEWPNEW PAC METALS CORP | 485,000 | $1.95M | 0.91% | 0 | Timeline | ||
| ITAISHARES TR | 7,650 | $1.85M | 0.87% | 0 | Timeline | ||
| PMPHILIP MORRIS INTL INC | 10,000 | $1.81M | 0.84% | 0 | Timeline | ||
| CDECOEUR MNG INC | 96,132 | $1.57M | 0.73% | 0 | Timeline | ||
| AGIALAMOS GOLD INC | 50,000 | $1.52M | 0.71% | 0 | Timeline | ||
| WPMWHEATON PRECIOUS METALS CORP | 12,500 | $1.4M | 0.66% | 0 | Timeline | ||
| NOCNORTHROP GRUMMAN CORP | 2,165 | $1.1M | 0.51% | 0 | Timeline | ||
| ELEELEMENTAL RTY CORP | 50,000 | $873K | 0.41% | 0 | Timeline | ||
| VMETVERSAMET ROYALTIES CORP | 66,621 | $821K | 0.38% | 0 | Timeline | ||
| DCDAKOTA GOLD CORP | 122,921 | $524K | 0.24% | 0 | Timeline | ||
| AMRZAMRIZE LTD | 9,175 | $489K | 0.23% | 0 | Timeline | ||
| ALTALTIMMUNE INC | 160,000 | $486K | 0.23% | 0 | Timeline | ||
| PHARPHARMING GROUP NV | 4,091 | $56.8K | 0.03% | +34 | Timeline | ||
| Orgenesis, Inc.Orgenesis, Inc. | 50,623 | $20.8K | 0.01% | 0 |
Sold out in Q2 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| CRDLCARDIOL THERAPEUTICS INC | 100,000 | $135K | shares |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001104659-26-097070 | superseded | 2026-08-14 | acceptance time not in the bulk data set | ||
| 13F-HR/A 0001104659-26-106457 | base | restatement | 2026-09-10 |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR/A 0001104659-26-106457 | Quarter ended 2026-06-30 | 2026-09-10 | ||
| 13F-HR 0001104659-26-097070 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-26-062445 | Quarter ended 2026-03-31 | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-26-016376 | Quarter ended 2025-12-31 | 2026-02-17 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-25-112578 | Quarter ended 2025-09-30 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-25-078541 | Quarter ended 2025-06-30 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-25-049384 | Quarter ended 2025-03-31 | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-25-014391 | Quarter ended 2024-12-31 | 2025-02-18 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-24-118986 | Quarter ended 2024-09-30 | 2024-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-24-089595 | Quarter ended 2024-06-30 | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-24-061904 | Quarter ended 2024-03-31 | 2024-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-24-023617 | Quarter ended 2023-12-31 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-23-118123 | Quarter ended 2023-09-30 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-23-091702 | Quarter ended 2023-06-30 | 2023-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-23-060827 | Quarter ended 2023-03-31 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-23-021561 | Quarter ended 2022-12-31 | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-22-118490 | Quarter ended 2022-09-30 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-22-091332 | Quarter ended 2022-06-30 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-22-061328 | Quarter ended 2022-03-31 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-22-022678 | Quarter ended 2021-12-31 | 2022-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-21-139144 | Quarter ended 2021-09-30 | 2021-11-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-21-106284 | Quarter ended 2021-06-30 | 2021-08-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-21-080656 | Quarter ended 2021-03-31 | 2021-06-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-21-023937 | Quarter ended 2020-12-31 | 2021-02-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-20-125804 | Quarter ended 2020-09-30 | 2020-11-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-20-095528 | Quarter ended 2020-06-30 | 2020-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-20-062559 | Quarter ended 2020-03-31 | 2020-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-20-022015 | Quarter ended 2019-12-31 | 2020-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001104659-19-064196 | Quarter ended 2019-09-30 | 2019-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-19-040043 | Quarter ended 2019-06-30 | 2019-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-19-026565 | Quarter ended 2019-03-31 | 2019-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-19-008236 | Quarter ended 2018-12-31 | 2019-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-18-059931 | Quarter ended 2018-09-30 | 2018-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-18-044640 | Quarter ended 2018-06-30 | 2018-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-18-028860 | Quarter ended 2018-03-31 | 2018-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-18-008909 | Quarter ended 2017-12-31 | 2018-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-17-059028 | Quarter ended 2017-09-30 | 2017-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-17-043190 | Quarter ended 2017-06-30 | 2017-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-17-027485 | Quarter ended 2017-03-31 | 2017-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-17-008952 | Quarter ended 2016-12-31 | 2017-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-16-134459 | Quarter ended 2016-09-30 | 2016-11-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-16-119396 | Quarter ended 2016-06-30 | 2016-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-16-102574 | Quarter ended 2016-03-31 | 2016-05-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-16-083000 | Quarter ended 2015-12-31 | 2016-02-17 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-15-066011 | Quarter ended 2015-09-30 | 2015-11-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-15-049867 | Quarter ended 2015-06-30 | 2015-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-15-031597 | Quarter ended 2015-03-31 | 2015-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-15-010045 | Quarter ended 2014-12-31 | 2015-02-17 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001144204-14-072900 | Quarter ended 2014-09-30 | 2014-12-09 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-14-068774 | Quarter ended 2014-09-30 | 2014-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-14-050192 | Quarter ended 2014-06-30 | 2014-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-14-031318 | Quarter ended 2014-03-31 | 2014-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-14-009812 | Quarter ended 2013-12-31 | 2014-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-13-062244 | Quarter ended 2013-09-30 | 2013-11-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001144204-13-046088 | Quarter ended 2013-06-30 | 2013-08-15 | acceptance time not in the bulk data set |